Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPSTONE: Nomacopan in PNH
NCT03588026Phase 3Completed
- Sponsor
- Akari Therapeutics
- Start
- Jun 2018
- Primary completion
- Sep 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of nomacopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Akari Therapeutics. Started Jun 2018; status: completed.
02
Drugs
nomacopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03588026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588026.